Cargando…

SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual

The milder clinical manifestations of Omicron infection relative to pre-Omicron SARS CoV-2 raises the possibility that extensive evolution results in reduced pathogenicity. To test this hypothesis, we quantified induction of cell fusion and cell death in SARS CoV-2 evolved from ancestral virus durin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lustig, Gila, Ganga, Yashica, Rodel, Hylton, Tegally, Houriiyah, Jackson, Laurelle, Cele, Sandile, Khan, Khadija, Jule, Zesuliwe, Reedoy, Kajal, Karim, Farina, Bernstein, Mallory, Moosa, Mahomed-Yunus S., Archary, Derseree, de Oliveira, Tulio, Lessells, Richard, Abdool Karim, Salim S., Sigal, Alex
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709797/ https://www.ncbi.nlm.nih.gov/pubmed/36451879 http://dx.doi.org/10.1101/2022.11.23.22282673

Ejemplares similares

Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)
por: Khan, Khadija, et al.
Publicado: (2021)

SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
por: Cele, Sandile, et al.
Publicado: (2021)

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
por: Cele, Sandile, et al.
Publicado: (2021)

Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
por: Khan, Khadija, et al.
Publicado: (2022)

Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
por: Khan, Khadija, et al.
Publicado: (2022)

Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant
por: Khan, Khadija, et al.
Publicado: (2022)

Omicron infection enhances Delta antibody immunity in vaccinated persons
por: Khan, Khadija, et al.
Publicado: (2022)

SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape
por: Cele, Sandile, et al.
Publicado: (2022)

SARS-CoV-2 evolved during advanced HIV disease immunosuppression has Beta-like escape of vaccine and Delta infection elicited immunity
por: Cele, Sandile, et al.
Publicado: (2021)

HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave
por: Karim, Farina, et al.
Publicado: (2021)

Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb
por: Naicker, Nikita, et al.
Publicado: (2023)

Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death
por: Jackson, Laurelle, et al.
Publicado: (2018)

Aggregated Mycobacterium tuberculosis Enhances the Inflammatory Response
por: Rodel, Hylton E., et al.
Publicado: (2021)

Interference with HIV infection of the first cell is essential for viral clearance at sub-optimal levels of drug inhibition
por: Moyano, Ana, et al.
Publicado: (2020)

HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per Cell
por: Boullé, Mikaël, et al.
Publicado: (2016)

T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy
por: Lustig, Gila, et al.
Publicado: (2021)

Association Between Human Immunodeficiency Virus Viremia and Compromised Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant
por: Hwa, Shi-Hsia, et al.
Publicado: (2022)

Diminished HIV Infection of Target CD4+ T Cells in a Toll-Like Receptor 4 Stimulated in vitro Model
por: Cromarty, Ross, et al.
Publicado: (2019)

Betamethasone induces potent immunosuppression and reduces HIV infection in a PBMC in vitro model
por: Cromarty, Ross, et al.
Publicado: (2021)

Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor Agonists
por: Shey, Muki S., et al.
Publicado: (2016)

Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial
por: Mahomed, Sharana, et al.
Publicado: (2019)

Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
por: Fisher, Kimone Leigh, et al.
Publicado: (2020)

Higher mucosal antibody concentrations in women with genital tract inflammation
por: Sobia, Parveen, et al.
Publicado: (2021)

Unlocking the efficiency of genomics laboratories with robotic liquid-handling
por: Tegally, Houriiyah, et al.
Publicado: (2020)

Intracellular growth of Mycobacterium tuberculosis after macrophage cell death leads to serial killing of host cells
por: Mahamed, Deeqa, et al.
Publicado: (2017)

Correction: Intracellular growth of Mycobacterium tuberculosis after macrophage cell death leads to serial killing of host cells
por: Mahamed, Deeqa, et al.
Publicado: (2017)

Genital—Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women
por: Liebenberg, Lenine J. P., et al.
Publicado: (2017)

Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa
por: Pillay, Kimesha, et al.
Publicado: (2021)

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review
por: Mahomed, Sharana, et al.
Publicado: (2020)

Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility
por: Cromarty, Ross, et al.
Publicado: (2020)

Preventive HIV Vaccines-Leveraging on Lessons from the Past to Pave the Way Forward
por: Sobia, Parveen, et al.
Publicado: (2021)

Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women
por: Mazibuko-Motau, Noluthando, et al.
Publicado: (2022)

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition
por: Liebenberg, Lenine J. P., et al.
Publicado: (2019)

Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women
por: McKinnon, Lyle R., et al.
Publicado: (2018)

Performance of rapid antigen tests in identifying Omicron BA.4 and BA.5 infections in South Africa
por: Samsunder, Natasha, et al.
Publicado: (2023)

Similar Antibody Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Individuals Living Without and With Human Immunodeficiency Virus on Antiretroviral Therapy During the First South African Infection Wave
por: Snyman, Jumari, et al.
Publicado: (2021)

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
por: Abdool Karim, Salim S., et al.
Publicado: (2021)

Whole Genome Sequencing of SARS-CoV-2: Adapting Illumina Protocols for Quick and Accurate Outbreak Investigation during a Pandemic
por: Pillay, Sureshnee, et al.
Publicado: (2020)

Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial
por: Mahomed, Sharana, et al.
Publicado: (2020)

Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report
por: Giandhari, Jennifer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_btukt02l1i4234hidsgue3l3s8